Here, we report that CRISPR/Cas9-mediated editing of the ALS-linked human SOD1-G93A transgenes (hSOD1-G93A) in two transgenic models completely prevented the development of any signs of clinical ALS or ALS pathology. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.